Literature DB >> 31439547

Studying Cancer Evolution and Therapeutic Responses in Different Organs: The Pros and Cons of a Broad Focus.

Catherine Pham-Danis1, James DeGregori2,3,4,5.   

Abstract

Cellular adaptation brought upon by insults such as old age and therapeutic exposure is a complex phenomenon in which cells undergo adaptive phenotypic changes. Our lab has focused on understanding the mechanisms underlying adaptation during the evolution of cancer, from the early stages of development to the ability of cancer cells to escape therapeutic challenges. Our studies span hematopoietic and lung systems. Herein, we discuss the advantages and disadvantages involved in studying two vastly different organ systems. Through the use of these organ/cancer model systems, we hope to develop interventions to limit oncogenic adaptation leading to cancer development and to prevent adaptation of cancers following treatment leading to cancer relapse. ©2019 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31439547      PMCID: PMC6744964          DOI: 10.1158/0008-5472.CAN-19-1303

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  9 in total

1.  Urea Cycle Sustains Cellular Energetics upon EGFR Inhibition in EGFR-Mutant NSCLC.

Authors:  Catherine Pham-Danis; Sarah Gehrke; Etienne Danis; Andrii I Rozhok; Michael W Daniels; Dexiang Gao; Christina Collins; José T Di Paola; Angelo D'Alessandro; James DeGregori
Journal:  Mol Cancer Res       Date:  2019-02-26       Impact factor: 5.852

Review 2.  Lung cancer in never smokers: clinical epidemiology and environmental risk factors.

Authors:  Jonathan M Samet; Erika Avila-Tang; Paolo Boffetta; Lindsay M Hannan; Susan Olivo-Marston; Michael J Thun; Charles M Rudin
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

3.  Tankyrase and the canonical Wnt pathway protect lung cancer cells from EGFR inhibition.

Authors:  Matias Casás-Selves; Jihye Kim; Zhiyong Zhang; Barbara A Helfrich; Dexiang Gao; Christopher C Porter; Hannah A Scarborough; Paul A Bunn; Daniel C Chan; Aik Choon Tan; James DeGregori
Journal:  Cancer Res       Date:  2012-06-27       Impact factor: 12.701

4.  ATM/G6PD-driven redox metabolism promotes FLT3 inhibitor resistance in acute myeloid leukemia.

Authors:  Mark A Gregory; Angelo D'Alessandro; Francesca Alvarez-Calderon; Jihye Kim; Travis Nemkov; Biniam Adane; Andrii I Rozhok; Amit Kumar; Vijay Kumar; Daniel A Pollyea; Michael F Wempe; Craig T Jordan; Natalie J Serkova; Aik Choon Tan; Kirk C Hansen; James DeGregori
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-10       Impact factor: 11.205

5.  Wnt/Ca2+/NFAT signaling maintains survival of Ph+ leukemia cells upon inhibition of Bcr-Abl.

Authors:  Mark A Gregory; Tzu L Phang; Paolo Neviani; Francesca Alvarez-Calderon; Christopher A Eide; Thomas O'Hare; Vadym Zaberezhnyy; Richard T Williams; Brian J Druker; Danilo Perrotti; James Degregori
Journal:  Cancer Cell       Date:  2010-07-13       Impact factor: 31.743

6.  Contrasting roles for C/EBPα and Notch in irradiation-induced multipotent hematopoietic progenitor cell defects.

Authors:  Courtney Jo Fleenor; Andrii Ivan Rozhok; Vadym Zaberezhnyy; Divij Mathew; Jihye Kim; Aik-Choon Tan; Irwin David Bernstein; James DeGregori
Journal:  Stem Cells       Date:  2015-04       Impact factor: 6.277

7.  Aging-associated inflammation promotes selection for adaptive oncogenic events in B cell progenitors.

Authors:  Curtis J Henry; Matias Casás-Selves; Jihye Kim; Vadym Zaberezhnyy; Leila Aghili; Ashley E Daniel; Linda Jimenez; Tania Azam; Eoin N McNamee; Eric T Clambey; Jelena Klawitter; Natalie J Serkova; Aik Choon Tan; Charles A Dinarello; James DeGregori
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

8.  Rapid modelling of cooperating genetic events in cancer through somatic genome editing.

Authors:  Francisco J Sánchez-Rivera; Thales Papagiannakopoulos; Rodrigo Romero; Tuomas Tammela; Matthew R Bauer; Arjun Bhutkar; Nikhil S Joshi; Lakshmipriya Subbaraj; Roderick T Bronson; Wen Xue; Tyler Jacks
Journal:  Nature       Date:  2014-10-22       Impact factor: 49.962

Review 9.  Overview of the Use of Murine Models in Leukemia and Lymphoma Research.

Authors:  Rebecca Kohnken; Pierluigi Porcu; Anjali Mishra
Journal:  Front Oncol       Date:  2017-02-20       Impact factor: 6.244

  9 in total
  1 in total

1.  Identifying key questions in the ecology and evolution of cancer.

Authors:  Antoine M Dujon; Athena Aktipis; Catherine Alix-Panabières; Sarah R Amend; Amy M Boddy; Joel S Brown; Jean-Pascal Capp; James DeGregori; Paul Ewald; Robert Gatenby; Marco Gerlinger; Mathieu Giraudeau; Rodrigo K Hamede; Elsa Hansen; Irina Kareva; Carlo C Maley; Andriy Marusyk; Nicholas McGranahan; Michael J Metzger; Aurora M Nedelcu; Robert Noble; Leonard Nunney; Kenneth J Pienta; Kornelia Polyak; Pascal Pujol; Andrew F Read; Benjamin Roche; Susanne Sebens; Eric Solary; Kateřina Staňková; Holly Swain Ewald; Frédéric Thomas; Beata Ujvari
Journal:  Evol Appl       Date:  2021-02-08       Impact factor: 5.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.